NAT INSTITUTE OF IMMUNOLOGY has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are HEPACORE LTD, THE CHEMO-SERO-THERAPEUTIC RES INST and VIREXX MEDICAL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Organic fine chemistry | |
#7 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Animal care | |
#7 | Analysing materials | |
#8 | Object sterilising | |
#9 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Panda Amulya Kumar | 4 |
#2 | Suri Anil Kumar | 2 |
#3 | Vijayan Viji | 2 |
#4 | Meena Jairam | 2 |
#5 | Vrati Sudhanshu | 2 |
#6 | Gupta Sarika | 2 |
#7 | Kumar Sanjay | 1 |
#8 | Kumar Gyanendra | 1 |
#9 | Chakraborty Kausik | 1 |
#10 | Surolia Namita | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020121336A1 | A method of mimicking benefits of dietary restriction by transiently upregulating er stress response | |
WO2019239369A1 | Blm mediated reactivation of fbw7a mutants in cancer | |
WO2019211866A1 | Carboxylated osteocalcin for treatment of amyloidosis or diseases associated with abnormal protein folding | |
WO2019211865A1 | Peptide complex with immunomodulatory and anti-inflammatory function | |
US2019134177A1 | Conjugate for vaccination against typhoid comprising chemical conjugate of vi polysaccharide and flagellin, a process for producing the same and a composition comprising the conjugate | |
AU2006219666A1 | Inhibition of SPAG9 expression with siRNAs | |
AU2004312444A1 | Recombinant vaccine against Japanese encephalitis virus (JEV) infection and a method thereof |